We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+4.39%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$5.04B
AUM Growth
+$1.26B
Cap. Flow
+$1.24B
Cap. Flow %
24.63%
Top 10 Hldgs %
29.33%
Holding
6,215
New
531
Increased
2,728
Reduced
2,144
Closed
536

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$165M
2
MSFT icon
Microsoft
MSFT
+$143M
3
NVDA icon
NVIDIA
NVDA
+$128M
4
AMZN icon
Amazon
AMZN
+$86.4M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$63.4M

Sector Composition

Rank Sector Weight
1 Technology 28.99%
2 Financials 11.06%
3 Consumer Discretionary 10.07%
4 Communication Services 8.96%
5 Healthcare 8.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FFIC
3151
DELISTED
Flushing Financial
FFIC
$20.9K ﹤0.01%
1,466
-3,483
-70% -$55.5K
APLT
3152
DELISTED
Applied Therapeutics
APLT
$20.9K ﹤0.01%
24,425
+23,893
+4,491% +$150K
CTEV
3153
Claritev Corp
CTEV
$675M
$20.9K ﹤0.01%
1,412
-92
-6% -$812
MSB
3154
Mesabi Trust
MSB
$305M
$20.8K ﹤0.01%
741
+472
+175% +$12.3K
SMTI icon
3155
Sanara MedTech
SMTI
$314M
$20.8K ﹤0.01%
626
+302
+93% +$10.2K
TRUP icon
3156
Trupanion
TRUP
$1.34B
$20.6K ﹤0.01%
428
-17,371
-98% -$892K
NREF
3157
NexPoint Real Estate Finance
NREF
$319M
$20.6K ﹤0.01%
1,314
+257
+24% +$4.11K
LWAY icon
3158
Lifeway Foods
LWAY
$396M
$20.6K ﹤0.01%
831
-4,817
-85% -$120K
ATEX icon
3159
Anterix
ATEX
$1.78B
$20.6K ﹤0.01%
671
-7,128
-91% -$237K
LTM
3160
LATAM Airlines Group S.A.
LTM
$15B
$20.5K ﹤0.01%
745
+562
+307% +$15.4K
SGMO
3161
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$20.5K ﹤0.01%
+20,141
New +$36.8K
ASAI
3162
DELISTED
Sendas Distribuidora S.A. American Depositary Share (each representing five common shares)
ASAI
$20.5K ﹤0.01%
4,591
+2,987
+186% +$17.4K
KSCP icon
3163
Knightscope
KSCP
$32M
$20.5K ﹤0.01%
1,624
+207
+15% +$3K
VPG icon
3164
Vishay Precision Group
VPG
$954M
$20.5K ﹤0.01%
872
-2,873
-77% -$67.2K
GRSD
3165
Grandstand Limited Ordinary Shares
GRSD
$77.2M
$20.4K ﹤0.01%
1,451
-693
-32% -$8.15K
WOW
3166
DELISTED
WideOpenWest
WOW
$20.4K ﹤0.01%
4,118
+859
+26% +$4.39K
GHM icon
3167
Graham Corp
GHM
$1.3B
$20.4K ﹤0.01%
459
-192
-29% -$7.19K
TXO icon
3168
TXO Partners LP
TXO
$777M
$20.4K ﹤0.01%
+1,212
New +$22K
NVNO
3169
enVVeno Medical
NVNO
$7.37M
$20.4K ﹤0.01%
193
+169
+704% +$18.9K
ADVM
3170
DELISTED
Adverum Biotechnologies
ADVM
$20.4K ﹤0.01%
4,362
+2,793
+178% +$18.8K
NECB icon
3171
Northeast Community Bancorp
NECB
$373M
$20.4K ﹤0.01%
832
+380
+84% +$10.4K
SBSW icon
3172
Sibanye-Stillwater
SBSW
$7.62B
$20.3K ﹤0.01%
6,157
-3,865
-39% -$16.3K
GNE icon
3173
Genie Energy
GNE
$384M
$20.3K ﹤0.01%
1,303
-606
-32% -$9.51K
IMCR icon
3174
Immunocore
IMCR
$1.73B
$20.2K ﹤0.01%
686
-276
-29% -$8.73K
USCB icon
3175
USCB Financial Holdings
USCB
$419M
$20.2K ﹤0.01%
1,137
+601
+112% +$10.5K

Similar funds

Tower Research Capital (TRC)'s Q4 2024 Portfolio in Review

As of Q4 2024, Tower Research Capital (TRC) held 6,215 positions worth $5.04B, up 33% from $3.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $1.24B of net new capital in Q4 2024, opening 531 new positions and adding to 2,728 existing holdings. Its largest new stake was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 22% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $296M trimmed.

  • Tower Research Capital (TRC)'s largest Q4 2024 buy was iShares MSCI USA Min Vol Factor ETF: 67,476 shares worth $5.99M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2024, an estimated $165M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2024 reduction was Invesco QQQ Trust, cutting an estimated $296M.
  • Tower Research Capital (TRC) fully exited iShares Russell 1000 ETF in Q4 2024, selling an estimated $30.5M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $5.04B portfolio in Q4 2024.
  • Tower Research Capital (TRC) opened 531 new positions and closed 536 in Q4 2024.
  • Tower Research Capital (TRC)'s portfolio value rose 33% quarter-over-quarter to $5.04B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2024, filed 13 Feb 2025.